tirzepatide body Study sees potential benefits of obesity drug in tackling type 2 diabetes A summary of the beneficial

By mimicking GLP-1, Ozempic makes you feel full and less hungry

The Food and Drug Administration (FDA) has approved Ozempic for Type 2 diabetes as well as to reduce the risk of major adverse cardiovascular events (such as heart attack or stroke) in adults with Type 2 diabetes and cardiovascular disease

This causes an increase in glucose-dependent insulin secretion which results in a decrease in glucagon secretion (by stimulating the release of insulin and suppressing the release of glucagon, the body thinks it has enough insulin and the body will in return slow down glucagon production/release)

10.2337/dc12-0709 23 RudolphM

However, as this evidence is currently limited to liraglutide, further research is warranted to explore wither similar dose-response variability exists for other anti-obesity medications

Its a great choice for those who are already seeing positive results with appetite control but want more support for weight loss and blood sugar management